News

Thousands of allergy pills recalled

Thousands of allergy pills recalled

RECALLED:Nearly 30,000 allergy tablets are being recalled. Photo: Reuters

MUMBAI (Reuters) – Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.

The loratadine and pseudoephedrine sulphate extended release tablets being recalled carry an expiry date of September 2015, and were manufactured by Ranbaxy’s Ohm Labs plant in New Jersey, which is the company’s only facility making generics for the United States.

All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches that the agency believed could compromise the quality of medicines.

Rival Indian drugmaker Sun Pharmaceutical Industries Ltd agreed to buy Ranbaxy last month in a $3.2 billion deal, betting it can fix Ranbaxy’s problems.

The FDA classified the recall by Ohm Labs as Class II, which means use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences.

Ranbaxy did not immediately respond to requests for comment.

(Reporting by Zeba Siddiqui in MUMBAI; Editing by Subhranshu Sahu)

Recent Headlines

in Entertainment, Sports

World Series of Poker starts this week with new events

Fresh
worldseriesofpoker

The annual set of 68 tournaments at the Rio Hotel & Casino that rewards millions of dollars to the best card sharks starts Wednesday.

in Local

Cortland superintendent: students lost were “full of potential”

Fresh
Local_News41-620x400

Superintendent Michael Hoose said students and staff are devastated in the wake of Friday's car crash that claimed the lives of two female students.

in Sports

Twins keep rolling

twins

Not many baseball fans expected the Minnesota Twins to be playoff contenders through Memorial Day, especially after their 1-6 start.

in Sports

Brady appeal to pass deadline

robertkraft

Tom Brady's appeal won't be heard by Wednesday's 10-day deadline.

in Sports

Tuesday’s Sports Minute

warriors

A look at some of the big sports stories making headlines today, Tuesday, May 26.